Aptevo Therapeutics Inc (APVO)
4.98
-0.19
(-3.68%)
USD |
NASDAQ |
Jan 08, 16:00
4.92
-0.06
(-1.20%)
After-Hours: 20:00
Aptevo Therapeutics SG&A Expense (Quarterly): 2.11M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Trevi Therapeutics Inc | 2.863M |
| Keros Therapeutics Inc | 9.82M |
| Johnson & Johnson | 5.278B |
| Eyenovia Inc | 3.729M |
| Applied Therapeutics Inc | 15.04M |